BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24318570)

  • 21. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.
    Awad O; Yustein JT; Shah P; Gul N; Katuri V; O'Neill A; Kong Y; Brown ML; Toretsky JA; Loeb DM
    PLoS One; 2010 Nov; 5(11):e13943. PubMed ID: 21085683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
    Ginestier C; Hur MH; Charafe-Jauffret E; Monville F; Dutcher J; Brown M; Jacquemier J; Viens P; Kleer CG; Liu S; Schott A; Hayes D; Birnbaum D; Wicha MS; Dontu G
    Cell Stem Cell; 2007 Nov; 1(5):555-67. PubMed ID: 18371393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
    Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
    Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
    Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
    J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
    Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
    In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells.
    Krishnamurthy S; Dong Z; Vodopyanov D; Imai A; Helman JI; Prince ME; Wicha MS; Nör JE
    Cancer Res; 2010 Dec; 70(23):9969-78. PubMed ID: 21098716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma.
    Zou B; Sun S; Qi X; Ji P
    Mol Med Rep; 2012 Apr; 5(4):1116-20. PubMed ID: 22307065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
    Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
    Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.
    Zhang G; Ma L; Xie YK; Miao XB; Jin C
    Mol Med Rep; 2012 Sep; 6(3):519-24. PubMed ID: 22684859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells.
    Kim SK; Kim H; Lee DH; Kim TS; Kim T; Chung C; Koh GY; Kim H; Lim DS
    PLoS One; 2013; 8(10):e78130. PubMed ID: 24194908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.
    Bortolomai I; Canevari S; Facetti I; De Cecco L; Castellano G; Zacchetti A; Alison MR; Miotti S
    Cell Cycle; 2010 Mar; 9(6):1194-206. PubMed ID: 20237414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALDH Activity Assay: A Method for Cancer Stem Cell (CSC) Identification and Isolation.
    Del Vecchio V; La Noce M; Tirino V
    Methods Mol Biol; 2024; 2777():83-89. PubMed ID: 38478337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.
    Thiagarajan PS; Hitomi M; Hale JS; Alvarado AG; Otvos B; Sinyuk M; Stoltz K; Wiechert A; Mulkearns-Hubert E; Jarrar A; Zheng Q; Thomas D; Egelhoff T; Rich JN; Liu H; Lathia JD; Reizes O
    Stem Cells; 2015 Jul; 33(7):2114-2125. PubMed ID: 25827713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem-Like Cells.
    Chen W; Allen SG; Qian W; Peng Z; Han S; Li X; Sun Y; Fournier C; Bao L; Lam RHW; Merajver SD; Fu J
    Small; 2019 Feb; 15(5):e1802891. PubMed ID: 30632269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
    Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
    Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression.
    Ortiz-Sánchez E; Santiago-López L; Cruz-Domínguez VB; Toledo-Guzmán ME; Hernández-Cueto D; Muñiz-Hernández S; Garrido E; Cantú De León D; García-Carrancá A
    Oncotarget; 2016 May; 7(22):31943-54. PubMed ID: 27008711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.
    Rasheed ZA; Yang J; Wang Q; Kowalski J; Freed I; Murter C; Hong SM; Koorstra JB; Rajeshkumar NV; He X; Goggins M; Iacobuzio-Donahue C; Berman DM; Laheru D; Jimeno A; Hidalgo M; Maitra A; Matsui W
    J Natl Cancer Inst; 2010 Mar; 102(5):340-51. PubMed ID: 20164446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line.
    Wang L; Park P; Zhang H; La Marca F; Claeson A; Valdivia J; Lin CY
    Cancer Biol Ther; 2011 Mar; 11(5):457-63. PubMed ID: 21178508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.